CN112867475B - 具有单分散流体体积的含颗粒液滴系统 - Google Patents
具有单分散流体体积的含颗粒液滴系统 Download PDFInfo
- Publication number
- CN112867475B CN112867475B CN201980068109.XA CN201980068109A CN112867475B CN 112867475 B CN112867475 B CN 112867475B CN 201980068109 A CN201980068109 A CN 201980068109A CN 112867475 B CN112867475 B CN 112867475B
- Authority
- CN
- China
- Prior art keywords
- droplet
- carrier particles
- particles
- carrier
- dimensional hydrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002245 particle Substances 0.000 title claims abstract description 1063
- 239000012530 fluid Substances 0.000 title claims abstract description 64
- 239000012071 phase Substances 0.000 claims abstract description 226
- 238000000034 method Methods 0.000 claims abstract description 87
- 239000000017 hydrogel Substances 0.000 claims abstract description 32
- 239000007790 solid phase Substances 0.000 claims abstract description 12
- 230000028327 secretion Effects 0.000 claims description 86
- 239000011800 void material Substances 0.000 claims description 71
- 239000000839 emulsion Substances 0.000 claims description 69
- 239000003153 chemical reaction reagent Substances 0.000 claims description 55
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 52
- 238000003556 assay Methods 0.000 claims description 44
- 238000009739 binding Methods 0.000 claims description 44
- 230000027455 binding Effects 0.000 claims description 43
- 239000011324 bead Substances 0.000 claims description 39
- 150000007523 nucleic acids Chemical class 0.000 claims description 37
- 229960002685 biotin Drugs 0.000 claims description 31
- 239000011616 biotin Substances 0.000 claims description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 31
- 108020004707 nucleic acids Proteins 0.000 claims description 29
- 102000039446 nucleic acids Human genes 0.000 claims description 29
- 235000020958 biotin Nutrition 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 26
- 108010090804 Streptavidin Proteins 0.000 claims description 25
- 239000000975 dye Substances 0.000 claims description 19
- 238000005406 washing Methods 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 239000000427 antigen Substances 0.000 claims description 9
- 102000036639 antigens Human genes 0.000 claims description 9
- 108091007433 antigens Proteins 0.000 claims description 9
- 230000021164 cell adhesion Effects 0.000 claims description 9
- 238000011068 loading method Methods 0.000 claims description 9
- 239000006249 magnetic particle Substances 0.000 claims description 9
- 238000000149 argon plasma sintering Methods 0.000 claims description 7
- 108020004999 messenger RNA Proteins 0.000 claims description 5
- 108091023037 Aptamer Proteins 0.000 claims description 4
- 230000018448 secretion by cell Effects 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 abstract description 8
- 210000004027 cell Anatomy 0.000 description 341
- 239000003921 oil Substances 0.000 description 112
- 229920002307 Dextran Polymers 0.000 description 99
- 229920001223 polyethylene glycol Polymers 0.000 description 92
- 239000000523 sample Substances 0.000 description 66
- 239000000243 solution Substances 0.000 description 66
- 239000008346 aqueous phase Substances 0.000 description 45
- 230000015572 biosynthetic process Effects 0.000 description 34
- 238000005538 encapsulation Methods 0.000 description 34
- 239000004094 surface-active agent Substances 0.000 description 34
- 238000004458 analytical method Methods 0.000 description 31
- 239000011159 matrix material Substances 0.000 description 29
- 239000000725 suspension Substances 0.000 description 29
- 238000004132 cross linking Methods 0.000 description 27
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 27
- 239000002953 phosphate buffered saline Substances 0.000 description 27
- 108090000623 proteins and genes Proteins 0.000 description 27
- 102000004169 proteins and genes Human genes 0.000 description 25
- 235000018102 proteins Nutrition 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 238000004945 emulsification Methods 0.000 description 22
- 238000003199 nucleic acid amplification method Methods 0.000 description 22
- 230000003321 amplification Effects 0.000 description 21
- 239000012491 analyte Substances 0.000 description 19
- 238000000926 separation method Methods 0.000 description 19
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- 230000008859 change Effects 0.000 description 16
- 239000003431 cross linking reagent Substances 0.000 description 15
- 238000000684 flow cytometry Methods 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 15
- 239000004971 Cross linker Substances 0.000 description 14
- 239000007864 aqueous solution Substances 0.000 description 14
- 230000008901 benefit Effects 0.000 description 14
- 239000000499 gel Substances 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 239000011859 microparticle Substances 0.000 description 14
- 238000002156 mixing Methods 0.000 description 14
- 230000001464 adherent effect Effects 0.000 description 13
- 230000009089 cytolysis Effects 0.000 description 13
- 239000002243 precursor Substances 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 238000013019 agitation Methods 0.000 description 11
- 230000021615 conjugation Effects 0.000 description 11
- 238000000799 fluorescence microscopy Methods 0.000 description 11
- 238000011534 incubation Methods 0.000 description 11
- 238000005191 phase separation Methods 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 10
- 239000012091 fetal bovine serum Substances 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 9
- 238000003384 imaging method Methods 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 238000003260 vortexing Methods 0.000 description 9
- PJDOLCGOTSNFJM-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctan-1-ol Chemical compound OCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F PJDOLCGOTSNFJM-UHFFFAOYSA-N 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- 239000011148 porous material Substances 0.000 description 8
- 238000012163 sequencing technique Methods 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 239000012099 Alexa Fluor family Substances 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- JUYQFRXNMVWASF-UHFFFAOYSA-M lithium;phenyl-(2,4,6-trimethylbenzoyl)phosphinate Chemical compound [Li+].CC1=CC(C)=CC(C)=C1C(=O)P([O-])(=O)C1=CC=CC=C1 JUYQFRXNMVWASF-UHFFFAOYSA-M 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 239000002105 nanoparticle Substances 0.000 description 7
- 238000010899 nucleation Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000011002 quantification Methods 0.000 description 7
- 239000012798 spherical particle Substances 0.000 description 7
- 230000035899 viability Effects 0.000 description 7
- OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- 239000006143 cell culture medium Substances 0.000 description 6
- -1 cells Substances 0.000 description 6
- 238000004581 coalescence Methods 0.000 description 6
- 238000009792 diffusion process Methods 0.000 description 6
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229920001992 poloxamer 407 Polymers 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 229920000936 Agarose Polymers 0.000 description 5
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000001879 gelation Methods 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 102000006495 integrins Human genes 0.000 description 5
- 108010044426 integrins Proteins 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 229960002378 oftasceine Drugs 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 150000003384 small molecules Chemical class 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000032258 transport Effects 0.000 description 5
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- 238000006596 Alder-ene reaction Methods 0.000 description 4
- 108091093088 Amplicon Proteins 0.000 description 4
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 108091006004 biotinylated proteins Proteins 0.000 description 4
- 238000007413 biotinylation Methods 0.000 description 4
- 230000006287 biotinylation Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000007847 digital PCR Methods 0.000 description 4
- 238000002073 fluorescence micrograph Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000010191 image analysis Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- 239000002122 magnetic nanoparticle Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 238000010587 phase diagram Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000003573 thiols Chemical class 0.000 description 4
- 230000001960 triggered effect Effects 0.000 description 4
- 229960003732 tyramine Drugs 0.000 description 4
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 238000007397 LAMP assay Methods 0.000 description 3
- DZGWFCGJZKJUFP-UHFFFAOYSA-N Tyramine Natural products NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 238000010079 rubber tapping Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 238000012174 single-cell RNA sequencing Methods 0.000 description 3
- 238000012289 standard assay Methods 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- DZGWFCGJZKJUFP-UHFFFAOYSA-O tyraminium Chemical compound [NH3+]CCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-O 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- VOBUAPTXJKMNCT-UHFFFAOYSA-N 1-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound CCCCCC(OC(=O)C=C)OC(=O)C=C VOBUAPTXJKMNCT-UHFFFAOYSA-N 0.000 description 2
- GTELLNMUWNJXMQ-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;prop-2-enoic acid Chemical class OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.CCC(CO)(CO)CO GTELLNMUWNJXMQ-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 238000006845 Michael addition reaction Methods 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000001268 conjugating effect Effects 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 238000012632 fluorescent imaging Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000011236 particulate material Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 2
- 238000005382 thermal cycling Methods 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- NNRFRJQMBSBXGO-CIUDSAMLSA-N (3s)-3-[[2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NNRFRJQMBSBXGO-CIUDSAMLSA-N 0.000 description 1
- PKYCWFICOKSIHZ-UHFFFAOYSA-N 1-(3,7-dihydroxyphenoxazin-10-yl)ethanone Chemical compound OC1=CC=C2N(C(=O)C)C3=CC=C(O)C=C3OC2=C1 PKYCWFICOKSIHZ-UHFFFAOYSA-N 0.000 description 1
- MUGYJXWDGQOBET-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;4-(2-aminoethyl)phenol Chemical compound NCCC1=CC=C(O)C=C1.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 MUGYJXWDGQOBET-UFLZEWODSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- YUGFLWBWAJFGKY-BQBZGAKWSA-N Arg-Cys-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O YUGFLWBWAJFGKY-BQBZGAKWSA-N 0.000 description 1
- ICAYWNTWHRRAQP-FXQIFTODSA-N Asp-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N)CN=C(N)N ICAYWNTWHRRAQP-FXQIFTODSA-N 0.000 description 1
- POTCZYQVVNXUIG-BQBZGAKWSA-N Asp-Gly-Pro Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O POTCZYQVVNXUIG-BQBZGAKWSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- GNMQDOGFWYWPNM-LAEOZQHASA-N Gln-Gly-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(O)=O GNMQDOGFWYWPNM-LAEOZQHASA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- YZACQYVWLCQWBT-BQBZGAKWSA-N Gly-Cys-Arg Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YZACQYVWLCQWBT-BQBZGAKWSA-N 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- VYWNORHENYEQDW-YUMQZZPRSA-N Pro-Gly-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 VYWNORHENYEQDW-YUMQZZPRSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- SVGAWGVHFIYAEE-JSGCOSHPSA-N Trp-Gly-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 SVGAWGVHFIYAEE-JSGCOSHPSA-N 0.000 description 1
- 101150110932 US19 gene Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 230000009833 antibody interaction Effects 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 108010089975 arginyl-glycyl-aspartyl-serine Proteins 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000003340 combinatorial analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006854 communication Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000000355 continuous-flow lithography Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000009295 crossflow filtration Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001808 exosome Anatomy 0.000 description 1
- 238000005206 flow analysis Methods 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229940097789 heavy mineral oil Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000008073 immune recognition Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 102000028557 immunoglobulin binding proteins Human genes 0.000 description 1
- 108091009323 immunoglobulin binding proteins Proteins 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000008611 intercellular interaction Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- 229940059904 light mineral oil Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920005650 polypropylene glycol diacrylate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003361 porogen Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 210000004986 primary T-cell Anatomy 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000003746 solid phase reaction Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000000661 stop-flow lithography Methods 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 239000002407 tissue scaffold Substances 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0026—Preparation of sols containing a liquid organic phase
- B01J13/003—Preparation from aqueous sols
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0052—Preparation of gels
- B01J13/0065—Preparation of gels containing an organic phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0052—Preparation of gels
- B01J13/0069—Post treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/44—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Power Engineering (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Life Sciences & Earth Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862719476P | 2018-08-17 | 2018-08-17 | |
| US62/719,476 | 2018-08-17 | ||
| PCT/US2019/046835 WO2020037214A1 (en) | 2018-08-17 | 2019-08-16 | Particle-containing droplet systems with monodisperse fluid volumes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112867475A CN112867475A (zh) | 2021-05-28 |
| CN112867475B true CN112867475B (zh) | 2024-03-22 |
Family
ID=69525873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980068109.XA Active CN112867475B (zh) | 2018-08-17 | 2019-08-16 | 具有单分散流体体积的含颗粒液滴系统 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210268465A1 (de) |
| EP (1) | EP3836887B1 (de) |
| JP (1) | JP2021534402A (de) |
| CN (1) | CN112867475B (de) |
| AU (1) | AU2019321593A1 (de) |
| CA (1) | CA3109426A1 (de) |
| WO (1) | WO2020037214A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107615062B (zh) | 2015-02-09 | 2022-03-18 | 弹弓生物科学公司 | 具有可调光学性质的水凝胶颗粒以及使用其的方法 |
| EP3331557B1 (de) | 2015-08-04 | 2021-04-07 | Duke University | Genetisch codierte intrinsisch ungeordnete stealth-polymere zur freisetzung und verfahren zur verwendung davon |
| US11752213B2 (en) | 2015-12-21 | 2023-09-12 | Duke University | Surfaces having reduced non-specific binding and antigenicity |
| US11467156B2 (en) | 2016-06-01 | 2022-10-11 | Duke University | Nonfouling biosensors |
| KR20190064600A (ko) | 2016-09-23 | 2019-06-10 | 듀크 유니버시티 | Lcst 거동을 갖는 비구조화된 비-반복적 폴리펩티드 |
| WO2018132732A1 (en) | 2017-01-12 | 2018-07-19 | Duke University | Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly |
| WO2018213320A1 (en) | 2017-05-15 | 2018-11-22 | Duke University | Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents |
| US11680083B2 (en) | 2017-06-30 | 2023-06-20 | Duke University | Order and disorder as a design principle for stimuli-responsive biopolymer networks |
| WO2020028806A1 (en) | 2018-08-02 | 2020-02-06 | Duke University | Dual agonist fusion proteins |
| US11512314B2 (en) | 2019-07-12 | 2022-11-29 | Duke University | Amphiphilic polynucleotides |
| US20220384081A1 (en) * | 2019-09-30 | 2022-12-01 | The Regents Of The University Of California | Electromagnetic systems for the selective manipulation of magnetically-barcoded materials |
| CA3167729A1 (en) | 2020-01-13 | 2021-07-22 | Fluent Biosciences Inc. | Emulsion based drug screening |
| AU2021207581A1 (en) * | 2020-01-13 | 2022-08-11 | Fluent Biosciences Inc. | Methods and systems for single cell gene profiling |
| JP2023511279A (ja) | 2020-01-13 | 2023-03-17 | フルーエント バイオサイエンシーズ インコーポレイテッド | 単一細胞シーケンシング |
| US11313782B2 (en) | 2020-01-24 | 2022-04-26 | Slingshot Biosciences, Inc. | Compositions and methods for cell-like calibration particles |
| AU2021232573A1 (en) * | 2020-03-04 | 2022-09-08 | Duke University | Protein nanoparticle design and application |
| CA3175931A1 (en) | 2020-03-16 | 2021-09-23 | Fluent Biosciences Inc. | Multi-omic analysis in monodisperse droplets |
| US20230173497A1 (en) * | 2020-04-29 | 2023-06-08 | Hewlett-Packard Development Company, L.P. | Nucleic acid amplification |
| US20230173449A1 (en) * | 2020-04-30 | 2023-06-08 | The Regents Of The University Of California | Systems and methods for multiphase droplet generation for generating shaped particles and uses thereof |
| JP2023524524A (ja) * | 2020-05-04 | 2023-06-12 | スリングショット バイオサイエンシーズ， インコーポレイテッド | 多重化アッセイのためのパッシブ光学バーコード付与のための組成物および方法 |
| US20230257732A1 (en) * | 2020-08-05 | 2023-08-17 | The Regents Of The University Of California | Degradable hollow shell particles for high-throughput screening and sorting of cells |
| WO2022240655A1 (en) * | 2021-05-10 | 2022-11-17 | The Regents Of The University Of California | Methods of using shaped particles in flow cytometers for assays on b cells and t cells |
| WO2022245827A1 (en) * | 2021-05-18 | 2022-11-24 | Fluent Biosciences Inc. | Pre-templated instant partitions for screening |
| CA3220479A1 (en) * | 2021-05-18 | 2022-11-24 | Fluent Biosciences Inc. | Template particles with micropores and nanopores |
| WO2023072809A1 (en) * | 2021-10-29 | 2023-05-04 | Droplet Genomics, Uab | Microspheroids containing distinguishable microparticle patterns |
| WO2023129514A2 (en) * | 2021-12-28 | 2023-07-06 | The Texas A&M University System | Environmental biospecimen recovery after in-droplet gel encapsulation |
| WO2024155630A2 (en) * | 2023-01-17 | 2024-07-25 | The Regents Of The University Of California | Therapeutic polynucleotides encoding t cell receptor (tcr) alpha chain polypeptides and/or tcr beta chain polypeptides |
| WO2024163462A1 (en) * | 2023-01-31 | 2024-08-08 | Genentech, Inc. | Magnetic hydrogel particles and methods of use |
| CN116259460B (zh) * | 2023-03-16 | 2024-03-19 | 重庆医科大学国际体外诊断研究院 | 两亲性磁纳米颗粒及其磁液滴微流控技术中的应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014012099A1 (en) * | 2012-07-13 | 2014-01-16 | Tufts University | Encapsulation of fragrance and/or flavors in silk fibroin biomaterials |
| CN105764490A (zh) * | 2013-09-24 | 2016-07-13 | 加利福尼亚大学董事会 | 用于生物测定和诊断的胶囊封装的传感器和感测系统及其制造和使用方法 |
| CN105979938A (zh) * | 2013-12-09 | 2016-09-28 | 香港大学 | 用于包封粒子、胶体和细胞的芯-壳胶囊 |
| CN106984247A (zh) * | 2017-05-11 | 2017-07-28 | 青岛大学 | 一种载亲水性材料的聚合物微胶囊的制备方法 |
| WO2018022581A1 (en) * | 2016-07-26 | 2018-02-01 | President And Fellows Of Harvard College | Barcoded systems with multiple information |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5583162A (en) * | 1994-06-06 | 1996-12-10 | Biopore Corporation | Polymeric microbeads and method of preparation |
| US20040127290A1 (en) | 1998-09-18 | 2004-07-01 | Walker Jay S. | Electronic amusement device and method for propagating a performance adjustment signal |
| GB2399084B (en) * | 2002-07-30 | 2007-01-31 | Univ Liverpool | Porous beads and method of production thereof |
| GB0311664D0 (en) | 2003-05-21 | 2003-06-25 | Univ Manchester | Polymeric hollow nanospheres |
| US7935518B2 (en) * | 2006-09-27 | 2011-05-03 | Alessandra Luchini | Smart hydrogel particles for biomarker harvesting |
| ES2623375T3 (es) | 2009-10-20 | 2017-07-11 | The Regents Of The University Of California | Holografía y microscopia celular incoherente sin lente en un chip |
| US9057702B2 (en) | 2010-12-21 | 2015-06-16 | The Regents Of The University Of California | Compact wide-field fluorescent imaging on a mobile device |
| CN107858218A (zh) | 2011-02-25 | 2018-03-30 | 美利肯公司 | 胶囊及包含其的组合物 |
| CN114891871A (zh) * | 2012-08-14 | 2022-08-12 | 10X基因组学有限公司 | 微胶囊组合物及方法 |
| US20140127290A1 (en) * | 2012-11-08 | 2014-05-08 | Ohio State Innovation Foundation | Microcapsules Encapsulating Living Cells |
| WO2016100234A1 (en) | 2014-12-15 | 2016-06-23 | The Regents Of The University Of California | Method and device for separation of particles and cells using gradient magnetic ratcheting |
| US20200292944A1 (en) * | 2015-11-18 | 2020-09-17 | Massachusetts Institute Of Technology | Method of making a patterned hydrogel and kit to make it |
| US10633493B2 (en) * | 2016-07-22 | 2020-04-28 | Northwestern University | Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation |
| WO2018156935A1 (en) * | 2017-02-24 | 2018-08-30 | The Regents Of The University Of California | Particle-drop structures and methods for making and using the same |
-
2019
- 2019-08-16 US US17/268,954 patent/US20210268465A1/en active Pending
- 2019-08-16 WO PCT/US2019/046835 patent/WO2020037214A1/en unknown
- 2019-08-16 JP JP2021507857A patent/JP2021534402A/ja active Pending
- 2019-08-16 CA CA3109426A patent/CA3109426A1/en active Pending
- 2019-08-16 EP EP19850668.5A patent/EP3836887B1/de active Active
- 2019-08-16 CN CN201980068109.XA patent/CN112867475B/zh active Active
- 2019-08-16 AU AU2019321593A patent/AU2019321593A1/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014012099A1 (en) * | 2012-07-13 | 2014-01-16 | Tufts University | Encapsulation of fragrance and/or flavors in silk fibroin biomaterials |
| CN105764490A (zh) * | 2013-09-24 | 2016-07-13 | 加利福尼亚大学董事会 | 用于生物测定和诊断的胶囊封装的传感器和感测系统及其制造和使用方法 |
| CN105979938A (zh) * | 2013-12-09 | 2016-09-28 | 香港大学 | 用于包封粒子、胶体和细胞的芯-壳胶囊 |
| WO2018022581A1 (en) * | 2016-07-26 | 2018-02-01 | President And Fellows Of Harvard College | Barcoded systems with multiple information |
| CN106984247A (zh) * | 2017-05-11 | 2017-07-28 | 青岛大学 | 一种载亲水性材料的聚合物微胶囊的制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| "Microfluidic synthesis of advanced microparticles for encapsulation and";Wynter J. Duncanson et.al;《CRITICAL REVIEW》;20121231;第2135–2145页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20210268465A1 (en) | 2021-09-02 |
| WO2020037214A1 (en) | 2020-02-20 |
| CN112867475A (zh) | 2021-05-28 |
| JP2021534402A (ja) | 2021-12-09 |
| EP3836887B1 (de) | 2024-07-17 |
| CA3109426A1 (en) | 2020-02-20 |
| EP3836887A4 (de) | 2021-10-13 |
| AU2019321593A1 (en) | 2021-03-18 |
| EP3836887A1 (de) | 2021-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112867475B (zh) | 具有单分散流体体积的含颗粒液滴系统 | |
| US20230167433A1 (en) | Methods and systems for increasing cell recovery efficiency | |
| US20220041967A1 (en) | Real-time monitoring of single cell or events | |
| EP4225934B1 (de) | Verfahren und zusammensetzungen zur analyse antigenbindender moleküle | |
| CN106574925A (zh) | 用于生物测定的底物介导的反应器 | |
| EP4022309B1 (de) | Verfahren zur analytenerkennung und -analyse | |
| KR101279918B1 (ko) | 종양세포 검출장치 및 종양세포 검출방법 | |
| Tiemeijer et al. | Hydrogels for single-cell microgel Production: Recent advances and applications | |
| KR101146263B1 (ko) | 특이적 결합분자?나노섬유 복합체 및 이의 제조방법 | |
| US20230295556A1 (en) | Selective enzymatic gelation | |
| US20230257732A1 (en) | Degradable hollow shell particles for high-throughput screening and sorting of cells | |
| US20230173449A1 (en) | Systems and methods for multiphase droplet generation for generating shaped particles and uses thereof | |
| WO2022240655A1 (en) | Methods of using shaped particles in flow cytometers for assays on b cells and t cells | |
| Chen et al. | Droplet-based microfluidics for single-cell encapsulation and analysis | |
| WO2018067789A1 (en) | Hydrogel display | |
| US20240327912A1 (en) | Methods of immune cell analysis | |
| WO2023093887A1 (zh) | 一种打破泊松分布形成反应隔室群的方法 | |
| WO2023215861A1 (en) | Reagents for characterizing antigen-binding molecules from immune cells | |
| WO2024015733A1 (en) | Improved methods and systems for identification and characterization of antigen-binding molecules from single cells | |
| WO2022174107A2 (en) | Method for assessing the opsonophagocytotic capacity or trogocytotic capacity of an antigen-binding molecule | |
| CN117480260A (zh) | 纳米级反应腔室及其使用方法 | |
| WO2024015856A1 (en) | Compositions and methods for characterizing binding characteristics of antigen binding molecules from single cells | |
| Celetti | Microfluidic for human health: a versatile tool for new progress in cancer diagnosis and contaminants detection | |
| 羽鳥万希子 | Development of vortex based droplet generation method and its applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |